Status:
COMPLETED
Trial on Profermin and Fresubin in Ulcerative Colitis
Lead Sponsor:
Nordisk Rebalance A/S
Collaborating Sponsors:
Hvidovre University Hospital
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study aim to investigate the effect of Profermin versus Fresubin in the dietetic treatment of active ulcerative colitis.
Eligibility Criteria
Inclusion
- Active ulcerative colitis (SCCAI =\>5 and \<=11)
- Access to Internet
Exclusion
- Stoma or intestinal resections
- Recent changes in UC medication
- Treatment with antibiotics
- Diabetes
- Celiac disease
- Lactose malabsorption
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT01193894
Start Date
August 1 2010
End Date
December 1 2012
Last Update
December 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Noreba
Allerød Municipality, Capital Region, Denmark, 3450